Stress contributes to the development of central insulin resistance during aging: Implications for Alzheimer's disease

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1832, Issue 12, 2013, Pages 2332-2339

  Solas, Maite ^a   Aisa, Bárbara ^a   Tordera, Rosa M ^a   Mugueta, María C ^b   Ramírez, María J ^a,c  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

^c UNIVERSITY OF NAVARRA   (Spain)

Author keywords

A ; Cognitive deficit; Glucocorticoid receptor; JNK; Mineralocorticoid receptor; Tau

Indexed keywords

MINERALOCORTICOID RECEPTOR; STRESS ACTIVATED PROTEIN KINASE;

AGING; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; HIPPOCAMPUS; INSULIN RESISTANCE; INTRACELLULAR SIGNALING; LONG TERM EXPOSURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRESS;

EID: 84885079975     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2013.09.013     Document Type: Article

References (65)

1. McEwen B.S. Sex, stress and the hippocampus: allostasis, allostatic load and the aging process. Neurobiol. Aging 2002, 23:921-939.
2. Miller D.B., O'Callaghan J.P. Neuroendocrine aspects of the response to stress. Metabolism 2002, 51:5-10.
3. Ownby R.L., Crocco E., Acevedo A., John V., Loewenstein D. Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch. Gen. Psychiatry 2002, 63:530-538.
4. Wilson R.S., Barnes L.L., Bennett D.A., Li Y., Bienias J.L., Mendes de Leon C.F., Evans D.A. Proneness to psychological distress and risk of Alzheimer disease in a biracial community. Neurology 2005, 64:380-382.
5. Armario A. The hypothalamic-pituitary-adrenal axis: what can it tell us about stressors?. CNS Neurol. Disord. Drug Targets 2006, 5:485-501.
6. Sapolsky R.M., Krey L.C., McEwen B.S. The adrenocortical stress-response in the aged male rat: impairment of recovery from stress. Exp. Gerontol. 1983, 18:55-64.
7. Kudielka B.M., Schmidt-Reinwald A.K., Hellhammer D.H., Schürmeyer T., Kirschbaum C. Psychosocial stress and HPA functioning: no evidence for a reduced resilience in healthy elderly men. Stress 2000, 3:229-420.
8. McEwen B.S. Stress and the aging hippocampus. Front. Neuroendocrinol. 1999, 20:49-70.
9. Piroli G.G., Grillo C.A., Reznikov L.R., Adams S., McEwen B.S., Charron M.J., Reagan L.P. Corticosterone impairs insulin-stimulated translocation of GLUT4 in the rat hippocampus. Neuroendocrinology 2007, 85:71-80.
10. Aisa B., Tordera R., Lasheras B., Del Río J., Ramírez M.J. Cognitive impairment associated to HPA axis hyperactivity after maternal separation in rats. Psychoneuroendocrinology 2007, 32:256-266.
11. Coluccia D., Wolf O.T., Kollias S., Roozendaal B., Forster A., de Quervain D.J. Glucocorticoid therapy-induced memory deficits: acute versus chronic effects. J. Neurosci. 2008, 28:3474-3478.
12. Abercrombie H.C., Jahn A.L., Davidson R.J., Kern S., Kirschbaum C., Halverson J. Cortisol's effects on hippocampal activation in depressed patients are related to alterations in memory formation. J. Psychiatr. Res. 2011, 45:15-23.
13. Sapolsky R.M. Glucocorticoid toxicity in the hippocampus: temporal aspects of neuronal vulnerability. Brain Res. 1985, 359:300-305.
14. Dhikav V., Anand K.S. Glucocorticoids may initiate Alzheimer's disease: a potential therapeutic role for mifepristone (RU-486). Med. Hypotheses 2007, 68:1088-1092.
15. Catania C., Sotiropoulos I., Silva R., Onofri C., Breen K.C., Sousa N., Almeida O.F. The amyloidogenic potential and behavioral correlates of stress. Mol. Psychiatry 2009, 14:95-105.
16. Green K.N., Billings L.M., Roozendaal B., McGaugh J.L., LaFerla F.M. Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer's disease. J. Neurosci. 2006, 26:9047-9056.
17. Jeong Y.H., Park C.H., Yoo J., Shin K.Y., Ahn S.M., Kim H.S., Lee S.H., Emson P.C., Suh Y.H. Chronic stress accelerates learning and memory impairments and increases amyloid deposition in APPV717I-CT100 transgenic mice, an Alzheimer's disease model. FASEB J. 2006, 20:729-731.
18. Harkin A., Houlihan D.D., Kelly J.P. Reduction in preference for saccharin by repeated unpredictable stress in mice and its prevention by imipramine. J. Psychopharmacol. 2002, 16:115-123.
19. Elizalde N., Gil-Bea F.J., Ramírez M.J., Aisa B., Lasheras B., Del Rio J., Tordera R.M. Long-lasting behavioral effects and recognition memory deficit induced by chronic mild stress in mice: effect of antidepressant treatment. Psychopharmacology 2008, 199:1-14.
20. Flanagan A.M., Brown J.L., Santiago C.A., Aad P.Y., Spicer L.J., Spicer M.T. High-fat diets promote insulin resistance through cytokine gene expression in growing female rats. J. Nutr. Biochem. 2008, 19:505-513.
21. Ribot J., Rodríguez A.M., Rodríguez E., Palou A. Adiponectin and resistin response in the onset of obesity in male and female rats. Obesity 2008, 16:723-730.
22. Solas M., Aisa B., Mugueta M.C., Del Río J., Tordera R.M., Ramírez M.J. Interactions between age, stress and insulin on cognition: implications for Alzheimer's disease. Neuropsychopharmacology 2010, 35:1664-1673.
23. Kyriakis J.M. Signaling by the germinal center kinase family of protein kinases. J. Biol. Chem. 1999, 274:5259-5262.
24. Sabio G., Das M., Mora A., Zhang Z., Jun J.Y., Ko H.J., Barrett T., Kim J.K., Davis R.J. A stress signaling pathway in adipose tissue regulates hepatic insulin resistance. Science 2008, 322:1539-1543.
25. Mandelkow E.M., Drewes G., Biernat J., Gustke N., Van Lint J., Vandenheede J.R., Mandelkow E. Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau. FEBS Lett. 1992, 314:315-321.
26. Sterlemann V., Rammes G., Wolf M., Liebl C., Ganea K., Müller M.B., Schmidt M.V. Chronic social stress during adolescence induces cognitive impairment in aged mice. Hippocampus 2010, 20:540-549.
27. Sandi C., Tourayot K. Mid-life stress and cognitive deficits during early aging in rats: individual differences and hippocampal correlates. Neurobiol. Aging 2006, 27:128-140.
28. Borcel E., Pérez-Alvarez L., Herrero A.I., Brionne T., Varea E., Berezin V., Bock E., Sandi C., Venero C. Chronic stress in adulthood followed by intermittent stress impairs spatial memory and the survival of newborn hippocampal cells in aging animals: prevention by FGL, a peptide mimetic of neural cell adhesion molecule. Behav. Pharmacol. 2008, 19:41-49.
29. Murphy E.K., Spencer R.L., Sipe K.J., Herman J.P. Decrements in nuclear glucocorticoid receptor (GR) protein levels and DNA binding in aged rat hippocampus. Endocrinology 2002, 143:1362-1370.
30. Schmidt M.V., Scharf S.H., Sterlemann V., Ganea K., Liebl C., Holsboer F., Müller M.B. High susceptibility to chronic social stress is associated with a depression-like phenotype. Psychoneuroendocrinology 2010, 35:635-643.
31. Xu Z., Zhang Y., Hou B., Gao Y., Wu Y., Zhang C. Chronic corticosterone administration from adolescence through early adulthood attenuates depression-like behaviors in mice. J. Affect. Disord. 2011, 131:128-135.
32. Joëls M., Van Riel E. Mineralocorticoid and glucocorticoid receptor-mediated effects on serotonergic transmission in health and disease. Ann. N. Y. Acad. Sci. 2004, 1032:301-303.
33. Gil-Bea F.J., Aisa B., Solomon A., Solas M., Mugueta M.C., Winblad B., Kivipelto M., Cedazo-Mínguez A., Ramírez M.J. HPA axis dysregulation associated to apolipoprotein E4 genotype in Alzheimer's disease. J. Alzheimers Dis. 2010, 22:829-838.
34. Cornelisse S., Joëls M., Smeets T. A randomized trial on mineralocorticoid receptor blockade in men: effects on stress responses, selective attention, and memory. Neuropsychopharmacology 2011, 36:2720-2728.
35. Amatruda J.M., Livingston J.N., Lockwood D.H. Cellular mechanisms in selected states of insulin resistance: human obesity, glucocorticoid excess, and chronic renal failure. Diabetes Metab. Rev. 1985, 1:293-317.
36. Kögel D., Schomburg R., Copanaki E., Prehn J.H. Regulation of gene expression by the amyloid precursor protein: inhibition of the JNK/c-Jun pathway. Cell Death Differ. 2005, 12:1-9.
37. Maruyama J., Naguro I., Takeda K., Ichijo H. Stress-activated MAP kinase cascades in cellular senescence. Curr. Med. Chem. 2009, 16:1229-1235.
38. Weston C.R., Davis R.J. The JNK signal transduction pathway. Curr. Opin. Cell Biol. 2007, 19:142-149.
39. de la Monte S.M., Wands J.R. Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease. J. Alzheimers Dis. 2005, 7:45-61.
40. Jimenez-Palomares M., Ramos-Rodriguez J.J., Lopez-Acosta J.F., Pacheco-Herrero M., Lechuga-Sancho A.M., Perdomo G., Garcia-Alloza M., Cozar-Castellano I. Increased Aβ production prompts the onset of glucose intolerance and insulin resistance. Am. J. Physiol. Endocrinol. Metab. 2012, 302:E1373-E1380.
41. van der Heide L.P., Ramakers G.M., Smidt M.P. Insulin signaling in the central nervous system: learning to survive. Prog. Neurobiol. 2006, 79:205-221.
42. Steen E., Terry B.M., Rivera E.J., Cannon J.L., Neely T.R., Tavares R., Xu X.J., Wands J.R., de la Monte S.M. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease-is this type 3 diabetes?. J. Alzheimers Dis. 2005, 7:63-80.
43. Schubert M., Gautam D., Surjo D., Ueki K., Baudler S., Schubert D., Kondo T., Alber J., Galldiks N., Küstermann E., Arndt S., Jacobs A.H., Krone W., Kahn C.R., Brüning J.C. Role for neuronal insulin resistance in neurodegenerative diseases. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:3100-3105.
44. Bogoyevitch M.A., Kobe B. Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases. Microbiol. Mol. Biol. Rev. 2006, 70:1061-1095.
45. El-Faramawy Y.A., El-Banouby M.H., Sergeev P., Mortagy A.K., Amer M.S., Abdel-Tawab A.M. Changes in glutamate decarboxylase enzyme activity and tau-protein phosphorylation in the hippocampus of old rats exposed to chronic mild stress: reversal with the neuronal nitric oxide synthase inhibitor 7-nitroindazole. Pharmacol. Biochem. Behav. 2009, 91:339-344.
46. Sotiropoulos I., Catania C., Riedemann T., Fry J.P., Breen K.C., Michaelidis T.M., Almeida O.F. Glucocorticoids trigger Alzheimer disease-like pathobiochemistry in rat neuronal cells expressing human tau. J. Neurochem. 2008, 107:385-397.
47. Xia Z., Dickens M., Raingeaud J., Davis R.J., Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995, 270:1326-1331.
48. Davis S., Laroche S. Mitogen-activated protein kinase/extracellular regulated kinase signaling and memory stabilization: a review. Genes Brain Behav. 2006, 5:61-72.
49. Ewers M., Buerger K., Teipel S.J., Scheltens P., Schröder J., Zinkowski R.P., Bouwman F.H., Schönknecht P., Schoonenboom N.S., Andreasen N., Wallin A., DeBernardis J.F., Kerkman D.J., Heindl B., Blennow K., Hampel H. Multicenter assessment of CSF-phosphorylated tau for the prediction of conversion of MCI. Neurology 2007, 69:2205-2212.
50. van der Vlies A.E., Verwey N.A., Bouwman F.H., Blankenstein M.A., Klein M., Scheltens P., van der Flier W.M. CSF biomarkers in relationship to cognitive profiles in Alzheimer disease. Neurology 2009, 72:1056-1061.
51. English J.D., Sweatt J.D. Activation of p42 mitogen-activated protein kinase in hippocampal long term potentiation. J. Biol. Chem. 1996, 271:24329-24332.
52. Eckel-Mahan K.L., Phan T., Han S., Wang H., Chan G.C., Scheiner Z.S., Storm D.R. Circadian oscillation of hippocampal MAPK activity and cAmp: implications for memory persistence. Nat. Neurosci. 2008, 11:1074-1082.
53. Ploj K., Roman E., Nylander I. Long-term effects of maternal separation on ethanol intake and brain opioid and dopamine receptors in male Wistar rats. Neuroscience 2003, 121:787-799.
54. Briones A., Gagno S., Martisova E., Dobarro M., Aisa B., Solas M., Tordera R., Ramírez M.J. Stress-induced anhedonia is associated with an increase in Alzheimer's disease-related markers. Br. J. Pharmacol. 2012, 165:897-907.
55. Yankner B.A., Dawes L.R., Fisher S., Villa-Komaroff L., Oster-Granite M.L., Neve R.L. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science 1989, 245:417-420.
56. Oster-Granite M.L., McPhie D.L., Greenan J., Neve R.L. Age-dependent neuronal and synaptic degeneration in mice transgenic for the C terminus of the amyloid precursor protein. J. Neurosci. 1996, 16:6732-6741.
57. Nalbantoglu J., Tirado-Santiago G., Lahsaïni A., Poirier J., Goncalves O., Verge G., Momoli F., Welner S.A., Massicotte G., Julien J.P., Shapiro M.L. Impaired learning and LTP in mice expressing the carboxy terminus of the Alzheimer amyloid precursor protein. Nature 1997, 387:500-505.
58. Berger-Sweeney J., McPhie D.L., Arters J.A., Greenan J., Oster-Granite M.L., Neve R.L. Impairments in learning and memory accompanied by neurodegeneration in mice transgenic for the carboxyl-terminus of the amyloid precursor protein. Mol. Brain Res. 1999, 66:150-162.
59. Tamagno E., Parola M., Bardini P., Piccini A., Borghi R., Guglielmotto M., Santoro G., Davit A., Danni O., Smith M.A., Perry G., Tabaton M. Beta-site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways. J. Neurochem. 2005, 92:628-636.
60. Tamagno E., Guglielmotto M., Giliberto L., Vitali A., Borghi R., Autelli R., Danni O., Tabaton M. JNK and ERK1/2 pathways have a dual opposite effect on the expression of BACE1. Neurobiol. Aging 2009, 30:1563-1573.
61. Takashima A., Honda T., Yasutake K., Michel G., Murayama O., Murayama M., Ishiguro K., Yamaguchi H. Activation of tau protein kinase I/glycogen synthase kinase-3beta by amyloid beta peptide (25-35) enhances phosphorylation of tau in hippocampal neurons. Neurosci. Res. 1998, 31:317-323.
62. Ghosal K., Vogt D.L., Liang M., Shen Y., Lamb B.T., Pimplikar S.W. Alzheimer's disease-like pathological features in transgenic mice expressing the APP intracellular domain. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:18367-18372.
63. Shipton O.A., Leitz J.R., Dworzak J., Acton C.E., Tunbridge E.M., Denk F., Dawson H.N., Vitek M.P., Wade-Martins R., Paulsen O., Vargas-Caballero M. Tau protein is required for amyloid {beta}-induced impairment of hippocampal long-term potentiation. J. Neurosci. 2011, 31:1688-1692.
64. Pearson A.G., Byrne U.T., MacGibbon G.A., Faull R.L., Dragunow M. Activated c-Jun is present in neurofibrillary tangles in Alzheimer's disease brains. Neurosci. Lett. 2006, 398:246-250.
65. Puig B., Gómez-Isla T., Ribé E., Cuadrado M., Torrejón-Escribano B., Dalfó E., Ferrer I. Expression of stress-activated kinases c-Jun N-terminal kinase (SAPK/JNK-P) and p38 kinase (p38-P), and tau hyperphosphorylation in neurites surrounding betaA plaques in APP Tg2576 mice. Neuropathol. Appl. Neurobiol. 2004, 30:491-502.